Commercializing Nanomedicine (PDF)

Luca Escoffier graduated in law from the University of Parma, Italy, and then earned a Master of Laws in intellectual property law in 2003 from the University of Turin/World Intellectual Property Organization. After spending several years in law firms, and in an Italian nanobiotech company, he moved to Seattle in 2008 to work as a visiting scholar, and then as a visiting lecturer, at the University of Washington. Escoffier is a Fellow of the Stanford-Vienna Transatlantic Technology Law Forum, invited researcher at Waseda University (Tokyo), and a Singularity University alumnus (GSP'10). He is a cofounder of Innoventually, one of the most innovative Open Innovation online portals, and works as cofounder, mentor, and consultant for several companies and organizations around the world.

Mario Ganau is a neurosurgeon and a global clinical scholar in clinical trials (Harvard Medical School, USA). He holds a PhD in nanotechnology (University of Trieste, Italy), CAS in management of biotech, medtech, and pharma ventures (Ecole polytechnique federale de Lausanne, Switzerland), DU in neuropharmacology (Universite Pierre et Marie Curie, France), MSBM in biological sciences (Universite Claude Bernard Lyon 1, France), and DIU in robotic surgery (Universite Henri Poincare, France). Featured in 2012 as a "Working Class Hero" by Wired Magazine Italia, he received the 2013 TOYP award for medical research by JCI, Italy, and a nomination for the Wired Audi Innovation Award 2014. Dr. Ganau is a cofounder and partner of iStarter, a startup incubator based in Turin and London.

Julielynn Wong is the founder of the Center for Innovative Technologies and Public Health, whose mission is to educate leaders on applying technologies to address the greatest challenges in healthcare. She worked at San Francisco-based Skoll Global Threats Fund to build "Flu Near You," the world's largest crowdsourced flu-tracking and vaccine locator platfor